Laronde
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
laronde.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Laronde
Sail Biomedicines is a pioneering company at the forefront of programmable medicines, utilizing a unique bioplatform that combines evolution and AI to develop innovative therapies. Their platform focuses on harnessing the therapeutic potential of eRNA and targeted nanoparticles (TNPs) to create a comprehensive toolkit for RNA medicines. By leveraging advanced AI algorithms and rapid prototyping, Sail aims to design and deploy RNA therapies for a range of diseases, including autoimmune, metabolic, infectious, and rare conditions. The company is dedicated to generating life-changing impacts through its cutting-edge technologies and data-driven approaches.Explore more
Laronde Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Laronde your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Laronde recently announced quarterly report
Click to see if Laronde had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Laronde
Website visits: Recent activity has been detected on your website
Laronde, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Laronde has new funding data
Check out if Laronde is spiking on competitors!
Check if Laronde has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Laronde launches new products
Recommended Actions
Reach out to Masked Content who joined Laronde as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Laronde is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Laronde is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Laronde.
Laronde financials insights
Gather financial insights about Laronde, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$440M
Laronde Tech Stack
A closer look at the technologies used by Laronde
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
New Hire
Executive Move
New Hire
Executive Move
Left Company
Executive Move
Laronde News & Media
Laronde Announces New Leadership
SOMERVILLE, Mass.--(BUSINESS WIRE)--Laronde Announces New LeadershipLaronde to Present at the RNA Leaders Europe Congress
Avak Kahvejian, Co-Founder and Chief Scientific Officer, to Present on "Programmable Medicines 2.0 with Endless RNA" SOMERVILLE, Mass., March 14, 2023 /PRNewswire/ -- Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express...Laronde Appoints Pablo J. Cagnoni as Chief Executive Officer
SOMERVILLE, Mass.--(BUSINESS WIRE)--Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express proteins inside the body for breakthrough treatments – today announced Pablo J. Cagnoni, M.D. as its Chief Executive Officer. Dr. Cagnoni, a Laronde board member since November 2021, succeeds John Mendlein, Flagship Pioneering Executive Partner and Laronde’s Chairman, who had been serving as the company’s interim CEO since August. Dr. CagnonLaronde Appoints John Mendlein as Chief Executive Officer
SOMERVILLE, Mass., Aug. 4, 2022 /PRNewswire/ -- Laronde, the company pioneering Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express proteins inside the body for breakthrough treatments – today announced that John Mendlein, Ph. D., the company's...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Laronde
Sign Up For FreeTo access detailed company insights
Sail Biomedicines is a pioneering company at the forefront of programmable medicines, utilizing a unique bioplatform that combines evolution and AI to develop innovative therapies. Their platform focuses on harnessing the therapeutic potential of eRNA and targeted nanoparticles (TNPs) to create a comprehensive toolkit for RNA medicines. By leveragi... Read More
